Division of Nephrology, Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Semin Nephrol. 2012 Nov;32(6):551-7. doi: 10.1016/j.semnephrol.2012.10.006.
Although hemodialysis patients who initiate and maintain a permanent form of dialysis vascular access have improved all-cause and cardiovascular survival compared with those who use catheters, the presence of an arteriovenous fistula has been shown to have a short-term, adverse effect on cardiac function. Through its effect as a left-to-right extracardiac shunt, the arteriovenous fistula can increase cardiac workload substantially, and, in certain patients, result in a high-output state and resultant heart failure over time. Here we review the mechanisms by which dialysis arteriovenous access may promote the development of high-output cardiac failure in end-stage renal disease patients, describe risk factors for and the diagnosis of high-output heart failure, and suggest management strategies for patients who develop high-output heart failure.
尽管与使用导管的患者相比,开始并维持永久性透析血管通路的血液透析患者全因死亡率和心血管死亡率有所改善,但动静脉瘘的存在已被证明对心脏功能有短期的不良影响。通过其作为左向右的心外分流的作用,动静脉瘘可大大增加心脏工作量,并且在某些患者中,随着时间的推移会导致高输出状态和心力衰竭。在这里,我们回顾了透析动静脉通路可能促进终末期肾病患者高输出性心力衰竭发展的机制,描述了高输出性心力衰竭的危险因素和诊断,并为发生高输出性心力衰竭的患者提出了管理策略。